| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4418800
[patent_doc_number] => 06225048
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Dendritic-marker expressing macrophage cultures and methods of reactivating latent virus'
[patent_app_type] => 1
[patent_app_number] => 9/164221
[patent_app_country] => US
[patent_app_date] => 1998-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16571
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/225/06225048.pdf
[firstpage_image] =>[orig_patent_app_number] => 164221
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/164221 | Dendritic-marker expressing macrophage cultures and methods of reactivating latent virus | Sep 29, 1998 | Issued |
Array
(
[id] => 4210069
[patent_doc_number] => 06086891
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Bi-functional plasmid that can act as both a DNA vaccine and a recombinant virus vector'
[patent_app_type] => 1
[patent_app_number] => 9/157963
[patent_app_country] => US
[patent_app_date] => 1998-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22435
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/086/06086891.pdf
[firstpage_image] =>[orig_patent_app_number] => 157963
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/157963 | Bi-functional plasmid that can act as both a DNA vaccine and a recombinant virus vector | Sep 20, 1998 | Issued |
Array
(
[id] => 7636698
[patent_doc_number] => 06379957
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Methods for HIV sequencing and genotyping'
[patent_app_type] => B1
[patent_app_number] => 09/158695
[patent_app_country] => US
[patent_app_date] => 1998-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5988
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/379/06379957.pdf
[firstpage_image] =>[orig_patent_app_number] => 09158695
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/158695 | Methods for HIV sequencing and genotyping | Sep 20, 1998 | Issued |
Array
(
[id] => 4007973
[patent_doc_number] => 05962325
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Three-dimensional stromal tissue cultures'
[patent_app_type] => 1
[patent_app_number] => 9/157306
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 40
[patent_no_of_words] => 12876
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962325.pdf
[firstpage_image] =>[orig_patent_app_number] => 157306
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/157306 | Three-dimensional stromal tissue cultures | Sep 17, 1998 | Issued |
Array
(
[id] => 4126337
[patent_doc_number] => 06146642
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Recombinant new castle disease virus RNA expression systems and vaccines'
[patent_app_type] => 1
[patent_app_number] => 9/152845
[patent_app_country] => US
[patent_app_date] => 1998-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9853
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/146/06146642.pdf
[firstpage_image] =>[orig_patent_app_number] => 152845
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/152845 | Recombinant new castle disease virus RNA expression systems and vaccines | Sep 13, 1998 | Issued |
Array
(
[id] => 4129686
[patent_doc_number] => 06121006
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Immunoassay utilizing two incubations with labeled antigen'
[patent_app_type] => 1
[patent_app_number] => 9/141887
[patent_app_country] => US
[patent_app_date] => 1998-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2444
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/121/06121006.pdf
[firstpage_image] =>[orig_patent_app_number] => 141887
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/141887 | Immunoassay utilizing two incubations with labeled antigen | Aug 27, 1998 | Issued |
Array
(
[id] => 4402852
[patent_doc_number] => 06270956
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/126980
[patent_app_country] => US
[patent_app_date] => 1998-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24698
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/270/06270956.pdf
[firstpage_image] =>[orig_patent_app_number] => 126980
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/126980 | Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor | Jul 29, 1998 | Issued |
Array
(
[id] => 4290328
[patent_doc_number] => 06268484
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'HIV-vaccines'
[patent_app_type] => 1
[patent_app_number] => 9/124900
[patent_app_country] => US
[patent_app_date] => 1998-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 12334
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268484.pdf
[firstpage_image] =>[orig_patent_app_number] => 124900
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/124900 | HIV-vaccines | Jul 29, 1998 | Issued |
Array
(
[id] => 4378966
[patent_doc_number] => 06277561
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Diagnostic assay for detection of HIV'
[patent_app_type] => 1
[patent_app_number] => 9/109916
[patent_app_country] => US
[patent_app_date] => 1998-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19080
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277561.pdf
[firstpage_image] =>[orig_patent_app_number] => 109916
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/109916 | Diagnostic assay for detection of HIV | Jul 1, 1998 | Issued |
Array
(
[id] => 4257244
[patent_doc_number] => 06204054
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Transcytosis vehicles and enchancers for drug delivery'
[patent_app_type] => 1
[patent_app_number] => 9/043412
[patent_app_country] => US
[patent_app_date] => 1998-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10069
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204054.pdf
[firstpage_image] =>[orig_patent_app_number] => 043412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/043412 | Transcytosis vehicles and enchancers for drug delivery | Jun 24, 1998 | Issued |
| 09/104295 | MEANS AND METHODS FOR MONITORING NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR ANTIRETROVIRAL THERAPY AND GUIDING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV/AIDS | Jun 23, 1998 | Abandoned |
Array
(
[id] => 4206031
[patent_doc_number] => 06027936
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'Carbon monoxide dependent guanyly cyclase modifiers and methods of use'
[patent_app_type] => 1
[patent_app_number] => 9/086878
[patent_app_country] => US
[patent_app_date] => 1998-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 39
[patent_no_of_words] => 17320
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/027/06027936.pdf
[firstpage_image] =>[orig_patent_app_number] => 086878
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/086878 | Carbon monoxide dependent guanyly cyclase modifiers and methods of use | May 28, 1998 | Issued |
Array
(
[id] => 4213266
[patent_doc_number] => 06110708
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Recombinant conglutinin and producing method thereof'
[patent_app_type] => 1
[patent_app_number] => 9/011735
[patent_app_country] => US
[patent_app_date] => 1998-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 5336
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/110/06110708.pdf
[firstpage_image] =>[orig_patent_app_number] => 011735
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/011735 | Recombinant conglutinin and producing method thereof | May 21, 1998 | Issued |
Array
(
[id] => 4355582
[patent_doc_number] => 06190863
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-20
[patent_title] => 'Sugar chain-recognizing antibodies and remedies for HIV infectious diseases'
[patent_app_type] => 1
[patent_app_number] => 9/077091
[patent_app_country] => US
[patent_app_date] => 1998-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 5063
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/190/06190863.pdf
[firstpage_image] =>[orig_patent_app_number] => 077091
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/077091 | Sugar chain-recognizing antibodies and remedies for HIV infectious diseases | May 18, 1998 | Issued |
Array
(
[id] => 4209922
[patent_doc_number] => 06086881
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Spatially aligned conjugated composition having a thioether bond linkage'
[patent_app_type] => 1
[patent_app_number] => 9/079374
[patent_app_country] => US
[patent_app_date] => 1998-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 14574
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/086/06086881.pdf
[firstpage_image] =>[orig_patent_app_number] => 079374
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/079374 | Spatially aligned conjugated composition having a thioether bond linkage | May 14, 1998 | Issued |
Array
(
[id] => 4001461
[patent_doc_number] => 06004763
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Antigen-carrying microparticles and their use in the induction of humoral or cellular responses'
[patent_app_type] => 1
[patent_app_number] => 9/076646
[patent_app_country] => US
[patent_app_date] => 1998-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 35
[patent_no_of_words] => 11609
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004763.pdf
[firstpage_image] =>[orig_patent_app_number] => 076646
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/076646 | Antigen-carrying microparticles and their use in the induction of humoral or cellular responses | May 11, 1998 | Issued |
Array
(
[id] => 1435615
[patent_doc_number] => 06355257
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors'
[patent_app_type] => B1
[patent_app_number] => 09/074720
[patent_app_country] => US
[patent_app_date] => 1998-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42254
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355257.pdf
[firstpage_image] =>[orig_patent_app_number] => 09074720
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/074720 | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors | May 6, 1998 | Issued |
Array
(
[id] => 4096503
[patent_doc_number] => 06048686
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Hyperthermia and immunotherapy for cancer'
[patent_app_type] => 1
[patent_app_number] => 9/073322
[patent_app_country] => US
[patent_app_date] => 1998-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3424
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048686.pdf
[firstpage_image] =>[orig_patent_app_number] => 073322
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/073322 | Hyperthermia and immunotherapy for cancer | May 4, 1998 | Issued |
| 09/071711 | RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86 FELINE CD28, FELINE CTLA-4 OR FELINE INTERFERON-Y AND USES THEREOF | Apr 30, 1998 | Abandoned |
Array
(
[id] => 4401614
[patent_doc_number] => 06171596
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Oligomeric HIV-1 envelope glycoproteins'
[patent_app_type] => 1
[patent_app_number] => 9/070291
[patent_app_country] => US
[patent_app_date] => 1998-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14929
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/171/06171596.pdf
[firstpage_image] =>[orig_patent_app_number] => 070291
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/070291 | Oligomeric HIV-1 envelope glycoproteins | Apr 29, 1998 | Issued |